Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FVXV0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,484
Award facts
- Contract value 100% obligated
- $16,484.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,484.08 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation, with a completion date of December 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for the DLA Medical Supply Chain, providing critical pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. The SPE2DX IDC vehicle enables the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Cosentyx, a specialty immunosuppressant medication, exemplifies the company's role in fulfilling federal medical procurement requirements for pharmaceutical products needed to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FVXV0?
SPE2DR26FVXV0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FVXV0 worth?
The government has obligated $16,484 on SPE2DR26FVXV0.
Is contract SPE2DR26FVXV0 an order under another contract?
Yes. SPE2DR26FVXV0 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.
Was contract SPE2DR26FVXV0 competed?
The extent of competition for SPE2DR26FVXV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award